Purchase Order HHSN263201400245P

<p>The Office of Logistics and Acquisition Operations issued a purchase order to Illumina, Inc. valued at $12,553.77 on July 7, 2015, with completion by July 16, 2016. No set-aside was used. Work is performed in San Diego, California. The order is firm fixed price. The source does not specify what equipment, reagents, consumables, or services are being purchased under this particular purchase order.</p>

<p>The National Institutes of Health Office of Logistics and Acquisition Operations awarded a purchase order to Illumina, Inc. for $13,293.26 on September 1, 2016, with ultimate completion on July 16, 2017. Performance occurs in Bethesda, Maryland. The order covers biotechnology sequencing instruments, reagents, consumables, or bioinformatics software. No set-aside applied.</p>

<p>The National Institutes of Health Office of Logistics and Acquisition Operations awarded a purchase order to Illumina, Inc. for $62,944.70 on March 16, 2026. This is a one-time fixed-price procurement for reagents with an ultimate completion date of January 15, 2027. Work is performed in San Diego, California.</p>

<p>The Office of Logistics and Acquisition Operations issued a $71,412.24 delivery order to Illumina, Inc. on July 31, 2017, for genetic sequencing equipment and services. Place of performance is San Diego, CA 92122. The order has an ultimate completion date of August 7, 2017 and is priced on a firm fixed-price basis with no set-aside applied.</p>

<p>The Office of Logistics and Acquisition Operations issued a $24,997.80 delivery order to Illumina, Inc. on September 17, 2017, for genomic analysis and sequencing services. Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of October 17, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $14,425.00 on January 31, 2018, with ultimate completion on February 1, 2019. Work is performed at North Bethesda, Maryland. The order is a firm fixed price commercial acquisition with no set-aside designation. Specific line items and scope details are not provided in the source material.</p>

Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.</p>

The National Institutes of Health, Office of Logistics and Acquisition Operations, issued a $344,017.95 delivery order to Illumina, Inc., on July 31, 2026, for Illumina reagents and consumables, with ultimate completion by December 31, 2026. Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside applied. This delivery order calls against one of Illumina's anchor IDIQs supporting reagent and consumable procurement across NIH institutes, reflecting the...